Marie-Emilie Willemin
5PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 16, 2024
Evaluation of Drug-Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model.Marie-Emilie Willemin, Jue Gong, Brandi W Hilder
|Jun 04, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart
|May 17, 2022
Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model.Marie-Emilie Willemin, Peter Zannikos, Geert Mannens
|Apr 11, 2021
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.Marie-Emilie Willemin, Thomas K Van Der Made, Ils Pijpers
Pageof 1
